Clinical Trial Update: Study of the Relative Oral Bioavailability of AL-3778 Tablets and Drug Interaction With Entecavir or Tenofovir Disoproxil Fumarate in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the relative oral bioavailability of AL-3778 tablets and potential interactions with Entecavir or Tenofovir disoproxil fumarate in heal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• AL-3778
• ENTECAVIR (ENTECAVIR)
• TENOFOVIR DISOPROXIL FUMARATE (tenofovir disoproxil fumarate)

Snippet

Sponsor: Alios Biopharma Inc. | Conditions: Hepatitis B, Chronic Hepatitis B | Phase 1 | Status: TERMINATED